⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175573 | 0.77 | TSHR (0.32) | — | |
| SCHEMBL2283357 | 0.74 | — | — | |
| SCHEMBL4560663 | 0.74 | — | — | |
| SCHEMBL7486373 | 0.74 | — | — | |
| SCHEMBL31385 | 0.72 | — | — | |
| SCHEMBL2467227 | 0.72 | — | — | |
| SCHEMBL8777745 | 0.72 | — | — | |
| SCHEMBL4618922 | 0.72 | — | — | |
| SCHEMBL7487256 | 0.70 | — | — | |
| SCHEMBL5664455 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2421858-A1 | THIOXANTHENE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES | BKG Pharma ApS (DK) | 2012-02-29 | — | — | EP | claimed |
| WO-2010122012-A1 | THIOXANTHENE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES | BKG PHARMA APS (DK) | 2010-10-28 | — | — | WO | claimed |
| EP-1664027-B1 | SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE | AMGEN INC (US) | 2009-12-30 | — | — | EP | claimed |
| EP-2114406-A1 | THIOXANTHENE DERIVATES USEFULTO TREAT INFECTIOUS DISEASES | BKG Pharma ApS (DK) | 2009-11-11 | — | — | EP | claimed |
| WO-2008080408-A1 | THIOXANTHENE DERIVATES USEFULTO TREAT INFECTIOUS DISEASES | BKG PHARMA APS (DK) | 2008-07-10 | — | — | WO | claimed |
| EP-1744781-A1 | TREATMENT OF INFECTIOUS DISEASES | Bkg Pharma Aps (DK) | 2007-01-24 | — | — | EP | claimed |
| WO-2005105145-A1 | TREATMENT OF INFECTIOUS DISEASES | BKG PHARMA APS (DK) | 2005-11-10 | — | — | WO | claimed |
| EP-0533244-B1 | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists | MERCK & CO INC (US) | 1997-12-17 | — | — | EP | claimed |
| US-4337262-A | HYPOTENSIVE AGENT, ANTICOAGULANT, VASODILATION, ANTIULCER AGENT, BRONCHODILATOR AGENT, ANTIALLERGEN, AND CONTRACEPTIVE | BURROUGHS WELLCOME CO. (US) | 1982-06-29 | — | — | US | claimed |
| EP-2421858-A1 | THIOXANTHENE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES | BKG Pharma ApS (DK) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010122012-A1 | THIOXANTHENE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES | BKG PHARMA APS (DK) | 2010-10-28 | — | — | WO | disclosed |
| EP-2114406-A1 | THIOXANTHENE DERIVATES USEFULTO TREAT INFECTIOUS DISEASES | BKG Pharma ApS (DK) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008080408-A1 | THIOXANTHENE DERIVATES USEFULTO TREAT INFECTIOUS DISEASES | BKG PHARMA APS (DK) | 2008-07-10 | — | — | WO | disclosed |
| US-20030162762-A1 | Novel cephalosporin compounds and process for preparing the same | LG LIFE SCIENCES LTD. (KR) | 2003-08-28 | — | — | US | disclosed |